TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
GEHC

GE HealthCare Technologies Inc.

Healthcare · Medical Devices

64.20$ -0.7% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Cash Flow

GE HealthCare Technologies Inc. (GEHC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -517 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow GEHC
Line item Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
520 520 578 -11 468 -19 622 1,042 468 -67 650 1,050 419 -119 738 913 250 94 593 1,051 290 -517 1,417
158 158 155 154 159 157 160 157 157 156 153 144 148 149 143 140 136 148 148 146 153 160 607
– – – – 19 20 19 9.0 24 28 29 33 34 36 22 33 22 34 38 36 35 45 154
– – – – – – -136 – 179 199 – – – – – – – – – – – – –
-383 -383 -168 -889 -10 -377 -35 166 85 -397 -146 213 154 -478 87 215 -143 -251 -87 260 -169 -58 -54
55 55 60 73 100 59 74 77 143 70 80 94 145 64 90 102 152 86 110 134 178 100 522
-73 -73 -84 -1,532 -100 -85 -118 -95 -266 -84 -120 -88 -188 -349 -137 -240 -407 -223 -148 -269 -2,500 -115 -3,032
– – – – – – – – 0.0 14 14 13 14 14 13 14 16 16 16 16 16 16 64
– – – – – – – – – -211 – – – -37 – – 0.0 -100 -100 0.0 -100 -200 -400
– – – – – – 8.0 – 1,985 -3.0 – – – – 987 -1,255 -256 1,489 -4.0 -261 148 -9.0 -126
-540 -540 -585 1,401 -420 140 -505 -37 673 -227 -24 -900 -153 -57 914 -1,277 -286 1,361 -165 -293 21 -446 -883
-98 -98 -103 -153 -55 24 -26 947 883 -389 475 86 59 -547 1,554 -679 -417 1,290 264 485 -2,227 -1,040 -2,518
465 465 518 -84 368 -78 548 965 325 -137 570 956 274 -183 648 811 98 8.0 483 917 112 -617 895

LTM = last twelve months (sum of the four most recent quarters).

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?